Skip to main content

Jaundice


Jaundice is the yellowish discolouration of the skin due to the presence of bilirubin, most commonly seen in infants. 


Bilirubin is a yellow compound that occurs in the normal catabolic pathway that breaks down haem in vertebrates, which is a necessary process in the body’s clearance of waste products that arise from the destruction of aged or abnormal red blood cells. Bilirubin in the blood is normally removed by the liver. However, because the livers of some infants are not yet fully developed, bilirubin is not broken down, resulting in jaundice. Consequently, newborns that are born prematurely have greater incidences of jaundice. 


Although generally harmless, extremely high levels of bilirubin can be harmful to the newborn. When bilirubin levels are high, there is a risk of bilirubin entering the brain, resulting in acute bilirubin encephalopathy. As bilirubin is toxic to brain cells, there is a possibility of permanent brain damage in the infant, otherwise known as kernicterus. 





Severe cases of jaundice are treated using phototherapy.


Phototherapy is treatment with a special type of light which lowers the bilirubin levels through a process called photo-oxidation. Photo-oxidation adds oxygen to bilirubin so it dissolves easily in water and is more easily broken down by the baby’s liver.

Comments

Post a Comment

Popular posts from this blog

Parkinson's Disease

Parkinson’s disease is a progressive nervous system disorder that affects one’s movements. Parkinson’s disease signs and symptoms are different for every individual and may go unnoticed in the early stage. Symptoms typically start on one side of the body and remain worse on that side even after the symptoms begin appearing in both sides of the body.  Generally, the symptoms of Parkinson’s disease include tremors, slowed movement, rigid muscles, impaired posture and balance, loss of automatic movements such as blinking or swinging of arms when walking, and speech and writing changes.  Parkinson’s disease occurs when neurons in an area of the brain that controls movement becomes impaired or dies. These neurons normally produce dopamine. As more neurons become impaired or die, the amount of dopamine produced in the body is reduced significantly, causing the movement problems associated with Parkinson’s disease.  People with Parkinson’s also lose the nerve endings that produc...
Post a Comment
Read more

Tinnitus

Tinnitus is a hearing condition often described as ringing in the ears. Tinnitus can also cause other types of noise in your ears such as: buzzing, roaring, clicking, hissing and humming.  The pitch heard from tinnitus can vary from a high squeal to a low roar, this can affect the patient’s ability to detect tinnitus from external sounds Tinnitus can develop gradually over time or occur suddenly. It is often associated with: age-related hearing loss, inner ear damage, earwax build-up and middle ear infection However, one in every three people with tinnitus doesn't have any obvious problem with their ears or hearing. Sources: https://www.mayoclinic.org/diseases-conditions/tinnitus/diagnosis-treatment/drc-20350162 http://www.webmd.com/a-to-z-guides/understanding-tinnitus-basics
Post a Comment
Read more

Pompe Disease

Pompe disease is a rare genetic condition where the body is unable to break down complex sugars. This is due to a deficiency in an enzyme called acid alfa glucosidase (GAA). Mutations in the GAA gene causes this disorder and results in a build up of glycogen in cells.  Pompe disease can appear in patients from within a few months of birth, at about 1 years old and even during the teenage years.  Those with Pompe disease usually inherit the disease from their parents. However, the allele for the disease is recessive, and may not be expressed in the parents. This disease is typically associated with weak muscles, poor muscle tone and an enlarged liver. However, there are many complications with regards to the respiratory system and motor skills which can also develop.  Enzyme replacement treatment is used for all Pompe patients. A drug called aglucosidase alfa is given intravenously, which acts as a replacement for GAA. Sources: https://my.clevelandclinic.org/health/disease...
Post a Comment
Read more